Norflurazepam Blister – 10x 10mg

A. Introduction

Norflurazepam Blister 10x 10mg is a premium laboratory-grade research chemical containing the benzodiazepine metabolite analog N-desalkylflurazepam, designed for scientific institutions and analytical laboratories investigating long-acting benzodiazepine standards. This high-purity 10x10mg blister format provides researchers with consistent dosage units for extended calibration curves, metabolic profiling, and quantitative analysis in controlled settings.

B. Scientific Overview

Norflurazepam (N-desalkylflurazepam) belongs to the 1,4-benzodiazepine class as an active metabolite of flurazepam, characterized by its desalkylated core scaffold with extended half-life properties suitable for analytical profiling. In research contexts, it functions as a primary reference standard for studying chromatographic retention, mass spectrometry transitions, and UV absorbance characteristics of benzodiazepine metabolites.

Laboratory investigations focus on its pharmacokinetic modeling parameters, protein binding affinity, and stability characteristics under bioanalytical conditions, without reference to biological interactions.

C. Product Specifications

• Form: Blister-packed units containing 10mg norflurazepam per tablet (10 tablets per pack)

• Label per unit: 10mg analytical portions in pharmaceutical-grade blister packaging

• Synonym: N-Desalkylflurazepam, Norflurazepam

• CAS Number: 2886-65-9

• Molecular Formula: C₁₅H₁₀ClFN₃O

• Molecular Weight: 287.72 g/mol

• Purity: ≥98% (HPLC, typical batch purity)

• Storage Conditions: Cool, dry place (2-8°C recommended), protected from light/moisture for stability

D. Laboratory Use Context

Norflurazepam Blister 10x 10mg is designated solely for in-vitro analytical research, including multi-concentration reference standard preparation, LC-MS/MS method optimization for benzodiazepine metabolites, forensic toxicology confirmation, and therapeutic drug monitoring validation across clinical ranges.

Researchers utilize the 10x10mg format for replicate analysis, stability indicating studies, and matrix effect evaluation using techniques such as SPE-LC-MS/MS, GC-NPD, and fluorescence detection. All applications must adhere to institutional laboratory safety standards and regulatory guidelines.

E. Quality & Testing

Every batch receives comprehensive quality control:

• Certificate of Analysis (COA) with HPLC, LC-MS/MS, NMR identity confirmation and content uniformity testing

• Full batch traceability from synthesis through tablet compression and blister sealing

• Third-party laboratory verification of purity, dissolution profile, and absence of process-related impurities

• Manufactured under controlled conditions ensuring consistent tablet potency (±3% RSD) and long-term stability

F. Shipping & Handling

Discreet worldwide shipping to verified research laboratories via secure, compliant carriers. Blister packaging inherently protects against moisture/light degradation while meeting IATA/DOT standards for benzodiazepine class research chemicals. Full customs documentation and tracking provided; buyers verify jurisdictional compliance prior to ordering.

G. Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product is supplied strictly as a laboratory reagent for analytical and research purposes only. It receives no approval for human, veterinary, diagnostic, or therapeutic use. No claims regarding pharmacological activity beyond controlled in-vitro analytical contexts.

Qualified researchers and institutions assume complete responsibility under applicable local, federal, and international regulations. Seller disclaims liability for misuse or diversion from authorized laboratory applications.